161 related articles for article (PubMed ID: 10692584)
1. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate.
Motohashi K; Shibata S; Ozaki Y; Yatomi Y; Igarashi Y
FEBS Lett; 2000 Feb; 468(2-3):189-93. PubMed ID: 10692584
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.
Yatomi Y; Ohmori T; Rile G; Kazama F; Okamoto H; Sano T; Satoh K; Kume S; Tigyi G; Igarashi Y; Ozaki Y
Blood; 2000 Nov; 96(10):3431-8. PubMed ID: 11071638
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate as an intercellular signaling molecule.
Igarashi Y
Ann N Y Acad Sci; 1998 Jun; 845():19-31. PubMed ID: 9668340
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid.
Yatomi Y; Yamamura S; Ruan F; Igarashi Y
J Biol Chem; 1997 Feb; 272(8):5291-7. PubMed ID: 9030602
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets.
Yatomi Y; Ruan F; Hakomori S; Igarashi Y
Blood; 1995 Jul; 86(1):193-202. PubMed ID: 7795224
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid-induced Ca2+ mobilization requires intracellular sphingosine 1-phosphate production. Potential involvement of endogenous EDG-4 receptors.
Young KW; Bootman MD; Channing DR; Lipp P; Maycox PR; Meakin J; Challiss RA; Nahorski SR
J Biol Chem; 2000 Dec; 275(49):38532-9. PubMed ID: 10954727
[TBL] [Abstract][Full Text] [Related]
7. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate.
Fueller M; Wang DA; Tigyi G; Siess W
Cell Signal; 2003 Apr; 15(4):367-75. PubMed ID: 12618211
[TBL] [Abstract][Full Text] [Related]
8. Activation of protein-tyrosine kinase Syk in human platelets stimulated with lysophosphatidic acid or sphingosine 1-phosphate.
Yang L; Yatomi Y; Hisano N; Qi R; Asazuma N; Satoh K; Igarashi Y; Ozaki Y; Kume S
Biochem Biophys Res Commun; 1996 Dec; 229(2):440-4. PubMed ID: 8954916
[TBL] [Abstract][Full Text] [Related]
9. [Elucidation of the functional roles of lysophospholipid mediators and its application in laboratory medicine].
Yatomi Y
Rinsho Byori; 2006 Jul; 54(7):720-31. PubMed ID: 16913663
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
Sandmann G; Siess W; Essler M
Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
[TBL] [Abstract][Full Text] [Related]
12. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
13. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
[TBL] [Abstract][Full Text] [Related]
14. N,N-dimethylsphingosine 1-phosphate activates human platelets.
Yatomi Y; Yamamura S; Ruan F; Kume S; Ozaki Y; Igarashi Y
FEBS Lett; 1997 Nov; 417(3):341-4. PubMed ID: 9409747
[TBL] [Abstract][Full Text] [Related]
15. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility.
Mettu PS; Deng PF; Misra UK; Gawdi G; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2263-71. PubMed ID: 15223804
[TBL] [Abstract][Full Text] [Related]
16. N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.
Yatomi Y; Ruan F; Megidish T; Toyokuni T; Hakomori S; Igarashi Y
Biochemistry; 1996 Jan; 35(2):626-33. PubMed ID: 8555236
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
18. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells.
Goetzl EJ; Dolezalova H; Kong Y; Zeng L
Cancer Res; 1999 Sep; 59(18):4732-7. PubMed ID: 10493533
[TBL] [Abstract][Full Text] [Related]
19. A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells.
Lyons JM; Karin NJ
J Bone Miner Res; 2001 Nov; 16(11):2035-42. PubMed ID: 11697799
[TBL] [Abstract][Full Text] [Related]
20. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.
Kranenburg O; Moolenaar WH
Oncogene; 2001 Mar; 20(13):1540-6. PubMed ID: 11313900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
